Filter Results :

Your search for Diseases returned 219 reports

Sort by


Global Orphan Diseases Partnering 2010-2016: Deal trends, players and financials

01 Apr 2016  |  Published by:  CurrentPartnering
The Global Orphan Diseases Partnering 2010-2016: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the orphan diseases partnering deals and agreements entered into by the worlds leading healthcare companies.Global Orphan Diseases Partnering 2...

$ 2,995.00

Read More

Global Infectious Diseases Partnering 2010-2016: Deal trends, players and financials

01 Apr 2016  |  Published by:  CurrentPartnering
Global Infectious Diseases Partnering 2010-2016: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the infectives partnering deals and agreements entered into by the worlds leading healthcare companies.Global Infectious Diseases Partnering 20...

$ 3,495.00

Read More

U.S. In Vitro Diagnostics (IVD) Market by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology), Application (Infectious Diseases, Diabetes, Cancer, Cardiology), End User (Hospitals & Laboratories) & by Region - Forecast to 2020

17 Mar 2016  |  Published by:  MarketsandMarkets
In vitro diagnostics testing is an indispensable tool in the modern medical practice. IVD tests are conducted with the help of various medical devices for the diagnosis of a number of diseases. With evolution in biotechnology, there has been a drastic change in the type of tests conducted for ...

$ 12,000.00

Read More

Rising Stars: New Emergence Of Potential TX & DX Options Could Transform The Current Landscape For Liver Diseases (Nash)

01 Feb 2016  |  Published by:  MP Advisors
Non-Alcoholic SteatoHepatitis (NASH) is an unmet medical need and is becoming the leading cause of liver transplant. No FDA-approved therapies and a meager diagnosis, it poses a unique challenge in the design of studies for NASH. Therefore, there is a worldwide need for new therapies to treat ...

$ 2,000.00
$ 1,800.00
( Save 10% )

Read More

Graves Diseases Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jan 2016  |  Published by:  DelveInsight
Summary'Graves Diseases- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufac...

$ 2,000.00

Read More

Inflammatory Skin Diseases Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jan 2016  |  Published by:  DelveInsight
Summary'Inflammatory Skin Diseases- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for ...

$ 2,000.00

Read More

Inflammatory Skin Diseases-Pipeline Insights, 2016

01 Jan 2016  |  Published by:  DelveInsight
Summary Inflammatory Skin Diseases- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Inflammatory Skin Diseases. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing a...

$ 1,250.00

Read More

Liver Diseases-Pipeline Insights, 2016

01 Jan 2016  |  Published by:  DelveInsight
SUMMARY'Liver Diseases-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Liver Diseases. This report provides information on the the...

$ 1,250.00

Read More

Motor Neurone Diseases-Pipeline Insights, 2016

01 Jan 2016  |  Published by:  DelveInsight
Summary Motor Neurone Diseases- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Motor Neurone Diseases. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-l...

$ 1,250.00

Read More

Graves Diseases-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

01 Jan 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Graves Diseases-API Insights, 2015,report provides Graves Diseases drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide cou...

$ 1,250.00

Read More

Mitral Valve Diseases Global Clinical Trials Review, H2, 2015

23 Dec 2015  |  Published by:  GlobalData
Summary“Mitral Valve Diseases Global Clinical Trials Review, H2, 2015" provides an overview of Mitral Valve Diseases clinical trials scenario. This report provides top line data relating to the clinical trials on Mitral Valve Diseases. Report includes an overview of trial numbers and their average e...

$ 2,500.00

Read More

Liver Diseases Global Clinical Trials Review, H2, 2015

16 Dec 2015  |  Published by:  GlobalData
Summary“Liver Diseases Global Clinical Trials Review, H2, 2015" provides an overview of Liver Diseases clinical trials scenario. This report provides top line data relating to the clinical trials on Liver Diseases. Report includes an overview of trial numbers and their average enrollment in top coun...

$ 2,500.00

Read More

Inflammatory Skin Diseases Global Clinical Trials Review, H2, 2015

30 Nov 2015  |  Published by:  GlobalData
Summary“Inflammatory Skin Diseases Global Clinical Trials Review, H2, 2015" provides an overview of Inflammatory Skin Diseases clinical trials scenario. This report provides top line data relating to the clinical trials on Inflammatory Skin Diseases. Report includes an overview of trial numbers and ...

$ 2,500.00

Read More

Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) Global Clinical Trials Review, H2, 2015

25 Nov 2015  |  Published by:  GlobalData
Summary “Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) Global Clinical Trials Review, H2, 2015" provides an overview of Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Inters...

$ 2,500.00

Read More

Global Neurodegenerative Diseases Drug Industry 2015 Market Research Report

20 Nov 2015  |  Published by:  QYResearch
The Global Neurodegenerative Diseases Drug Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Neurodegenerative Diseases Drug industry.The report provides a basic overview of the industry including definitions, classifications, applications and indu...

$ 2,800.00

Read More
Total 219 records.